Five Star Equities Provides Stock Research on Broadwind Energy and Kaydon
Continue ReadingTag: investment
Solar Stocks Soar on the Announcement of $2.5 Billion Deal Between SunPower and Warren Buffett-s MidAmerican Energy
The Paragon Report Provides Stock Research on SunPower and First Solar
Continue Reading
Biotech Industry Experiencing More FDA New Drug Approvals in 2012
Five Star Equities Provides Stock Research on Acorda Therapeutics and Peregrine Pharmaceuticals
Continue Reading
Gold Prices Surge as Deal to Avoid Fiscal Cliff “Within Sight”
The Paragon Report Provides Stock Research on Eldorado Gold and Kinross Gold
Continue Reading
Gold Posts 12th Consecutive Year of Gains With a 6% Increase in 2012
The Paragon Report Provides Stock Research on Yamana Gold and New Gold
Continue Reading
S&P 500 Index Posts a 13.4% Gain in 2012 — The Largest Since 2009
The Paragon Report Provides Stock Research on Caterpillar and Halliburton
Continue Reading
S&P 500 Index Posts Best Year Since 2009 — Bristol Myers Squibb and Johnson & Johnson Receive FDA Approvals
The Paragon Report Provides Stock Research on Bristol Myers Squibb and Johnson & Johnson
Continue Reading
Rare Industry Continues to Struggle With Low Prices and New Supplies — China Sets 2013 Rare Earth Exports Quotas
Five Star Equities Provides Stock Research on Rare Element Resources and Quest Rare Minerals
Continue Reading
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Progenics Pharmaceuticals and Vical
Continue Reading
Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases
Five Star Equities Provides Stock Research on Incyte and Oncolytics Biotech
Continue Reading